Fig. 2From: Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injuryLong-term adverse outcomes of immune checkpoint inhibitor (ICI)-initiated pancreatic injury by discontinuation of ICI therapy and use of intravenous fluidsBack to article page